Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Sequence Bio is a leading genomics company focused on understanding the genetic basis of disease in populations with unique genetic backgrounds, particularly in Newfoundland and Labrador, Canada. Their mission is to accelerate the development of precision medicine solutions by building a robust genomic database and partnering with pharmaceutical companies and research institutions.
Serves as the primary hub for company operations, research and development, and executive leadership.
Modern office space located in a historic building in downtown St. John's, designed to foster collaboration and innovation.
The headquarters fosters a collaborative and innovative work environment. The company values teamwork, scientific rigor, and a commitment to improving healthcare outcomes through genomics.
The St. John's headquarters is strategically located to leverage the unique genetic heritage of the Newfoundland and Labrador population, which is crucial to Sequence Bio's research efforts.
Sequence Bio primarily operates within Canada, with collaborations and partnerships extending to the US and Europe to support research initiatives and data analysis.
Suite 701, 351 Water Street
St. John's
Newfoundland and Labrador
Canada
Address: Information is not available
Expands Sequence Bio's reach and network in the Canadian pharmaceutical and research landscape.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Sequence' leadership includes:
Sequence has been backed by several prominent investors over the years, including:
There haven't been many publicly visible executive hires or exits reported for Sequence Bio in the last 12 months. Monitoring of public sources is continuing.
Discover the tools Sequence uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Sequence Bio's email format typically follows a first name.last name pattern.
[first].[last]@sequencebio.com
Format
john.doe@sequencebio.com
Example
80%
Success rate
Genome Canada • March 1, 2023
Genome Canada announced a partnership with IBM Canada to advance the Canadian Biogenome Project (CBP). Genome Atlantic is the regional Genome Centre leading the CBP’s Atlantic Node. One of their projects is the Newfoundland and Labrador Genome Project (NLGP) which will continue to build on Sequence Bio’s work around genomics....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Sequence, are just a search away.